Medicare billing address
CMS Medicare provider billing file
1055 N 500 WSte 111
Provo, UT 84604
CMS public data · NPI 1639490386
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Kevin H Gardner, DO
Specialty
Credential
DO
NPI
1639490386
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Kevin H Gardner, DO from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1055 N 500 WCMS Doctors & Clinicians file
700 S Hwy 99In the 2024 CMS provider billing file, this NPI had 604 Medicare beneficiaries and 3,560 total services. The average beneficiary age was 74, and the average HCC risk score was 0.8.
Total Medicare allowed amount
$437,978.44
Total Medicare payment amount
$327,260.98
Medicare beneficiaries
604
Total services
3,560
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
59%
CMS beneficiary-panel share
Hypertension
53%
CMS beneficiary-panel share
Ischemic heart disease
25%
CMS beneficiary-panel share
Chronic kidney disease
16%
CMS beneficiary-panel share
Diabetes
14%
CMS beneficiary-panel share
Mood disorders
13%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,318 | $6.11 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 404 | $85.80 |
| Destruction of precancer skin growth, 1 growth | 379 | $46.66 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 275 | $508.53 |
| Biopsy of related skin growth, first growth | 135 | $80.08 |
| Destruction of skin growth, 1-14 growths | 93 | $95.28 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 89 | $384.77 |
| Destruction of precancer skin growth, 15 or more growths | 79 | $156.70 |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 65 | $106.06 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 64 | $173.84 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1639490386. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Triamcinolone Acetonide | Triamcinolone Acetonide | 71 | 91.2 | $1,193.90 |
| 2 | Ketoconazole | Ketoconazole | 37 | 41.7 | $542.98 |
| 3 | Cephalexin | Cephalexin | 27 | 27 | $209.31 |
| 4 | Clobetasol Propionate | Clobetasol Propionate | 27 | 28 | $1,026.60 |
| 5 | Hydrocortisone | Hydrocortisone | 21 | 23.3 | $150.74 |
| 6 | Cosentyx Sensoready (2 Pens) | Secukinumab | 20 | 26.1 | $156,732.76 |
| 7 | Jublia | Efinaconazole | 18 | 21 | $14,228.75 |
| 8 | Clindamycin Phosphate | Clindamycin Phosphate | 13 | 13 | $337.79 |
| 9 | Minoxidil | Minoxidil | 13 | 13 | $152.00 |
| 10 | Taltz Autoinjector | Ixekizumab | 12 | 12 | $110,834.52 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2010
Group/practice field
Ihc Health Services Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.